Alzai Health Corp. ALZI.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 49.60K | 19.50K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.60K | 19.50K | -- | -- | -- |
| Cost of Revenue | 396.50K | 300.50K | -- | -- | -- |
| Gross Profit | -346.90K | -281.00K | -- | -- | -- |
| SG&A Expenses | 1.62M | 1.51M | -- | -- | -- |
| Depreciation & Amortization | 13.00K | 11.90K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93M | 2.64M | -- | -- | -- |
| Operating Income | -2.88M | -2.62M | -- | -- | -- |
| Income Before Tax | -2.98M | -2.66M | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.98 | -2.66 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.98M | -2.66M | -- | -- | -- |
| EBIT | -2.88M | -2.62M | -- | -- | -- |
| EBITDA | -2.88M | -2.62M | -- | -- | -- |
| EPS Basic | -0.05 | -0.05 | -- | -- | -- |
| Normalized Basic EPS | -0.03 | -0.03 | -- | -- | -- |
| EPS Diluted | -0.05 | -0.05 | -- | -- | -- |
| Normalized Diluted EPS | -0.03 | -0.03 | -- | -- | -- |
| Average Basic Shares Outstanding | 217.58M | 205.47M | -- | -- | -- |
| Average Diluted Shares Outstanding | 217.58M | 205.47M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |